Use of monoclonal antibodies for anticancer therapy

Abstract

Monoclonal antibody-based therapeutic approaches have a significant impact in the treatment of hematologic malignancies even solid tumors. Rituximab in combination with chemotherapy is now standard treatment for folicular lymphoma.

Keywords

• monoclonal antibodies
• Rhituximab
• chemotherapy
• lyphocytic leukemia
• mechanism of action
• monospecific antibodies
• conjugated antibodies
• bispecific antibodies
• antibodies of new generation